OCULAR THERAPEUTIX, INC business relationships
Companies named in OCULAR THERAPEUTIX, INC’s 10-K filed 2026-02-05, and public companies whose annual reports name OCULAR THERAPEUTIX, INC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.0 / 10
- AI naming
- 27 / 100 Top 1% in its category
- Agent readiness
- 30 / 100
- AI adoption
- 0 / 100
Named in OCULAR THERAPEUTIX, INC’s annual report 2
“For example, our former collaborator Regeneron terminated our collaboration in August 2021.” SEC filing
“For example, three of our licensed patents related to ReSure Sealant were invalidated and rendered unenforceable following their assertion by Integra LifeSciences Holdings Corporation, another licensee of Incept.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.